On Friday, the Food and Drug Administration (FDA) announced the issuance of a new Guidance document pertaining to nutrition labeling during the COVID-19 health crisis. It is intended to provide restaurants and food manufacturers with flexibility regarding nutrition labeling so that they can sell certain packaged foods during the current pandemic. This guidance does not apply to foods prepared by restaurants. The FDA intends to exercise enforcement discretion relative to compliant nutrition labeling in two ways during the ongoing pandemic:
Distribution of Foodservice-Labeled Foods for Retail Sale
Foods labeled for foodservice distribution (e.g., restaurants and other food service establishments) typically bear the same mandatory label information as retail foods, except the Nutrition Facts panel. The ongoing pandemic has created a situation in which many foodservice establishments are closed, and grocery shelves are sometimes devoid of hoarded food products. To address this situation, the FDA is permitting foodservice establishments and foodservice manufacturers to sell/distribute for retail sale foods (both perishable and non-perishable) that do not bear Nutrition Facts (provided that the food does not have any nutrition claims), but that do include the following mandatory information:
Furthermore, if retail packaging for certain food products is unavailable, the FDA does not intend to object to the further production of food labeled for use in foodservice establishments that is intended to be sold at retail until retail becomes available.
Postponement of Compliance Date for Revised Nutrition/Supplement Facts Panels
The FDA also announced that it would work cooperatively with manufacturers the first six months following the January 1, 2020, compliance date regarding using updated Nutrition and Supplement Facts labels and would not focus on enforcement actions during this time. The FDA now intends to do so through the remainder of 2020.
“Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency” is available here.
While this guidance document is effective immediately, comments still may be submitted in accordance with FDA’s good guidance practices.
OFW Law will continue to monitor for new guidance documents from the FDA and will be posting updates on our blog at OFWLaw.com. If you have any questions about these matters, please contact Michael O’Flaherty at firstname.lastname@example.org.